PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW144782View Pathway |
drug action
Pirenzepine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:25 Last Updated: October 07, 2023 at 14:25 |
PW126191View Pathway |
drug action
Pirenzepine M1 Ulcer Treatment Action PathwayHomo sapiens
Pirenzepine is a drug that targets antimuscarinic agents in order to treat ulcers, this is done through inhibiting gastic secretions in order to allow the ulver to heal. Pirenzepine belongs to antispasmodics and anticholinergics group, that are used to relieve cramping or spasming of the gastrointestinal tract. It can be used along with antacids to treat peptic ulcers, it can also be used to prevent nausea, vomiting and motion sickness. Pirenzepine acts on muscarinic acetylcholine receptor M1 antagonizing it and eliciting inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels.
|
Creator: Selena Created On: August 11, 2021 at 21:50 Last Updated: August 11, 2021 at 21:50 |
PW145519View Pathway |
drug action
Piretanide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:59 Last Updated: October 07, 2023 at 15:59 |
PW145620View Pathway |
drug action
Pirfenidone Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:14 Last Updated: October 07, 2023 at 16:14 |
PW176227View Pathway |
Pirfenidone Predicted Metabolism PathwayHomo sapiens
Metabolites of Pirfenidone are predicted with biotransformer.
|
Creator: Omolola Created On: December 04, 2023 at 12:56 Last Updated: December 04, 2023 at 12:56 |
PW146535View Pathway |
drug action
Piritramide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:26 Last Updated: October 07, 2023 at 18:26 |
PW128420View Pathway |
drug action
Piritramide Opioid Agonist Action PathwayHomo sapiens
Piritramide is an opioid analgesic used to treat severe pain. It is under investigation for the treatment of colon cancer and minimal residual disease.
Piritramide binds to mu, kappa, and delta opioid receptors on presynaptic neuron membranes, stimulating the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is inhibited. Opioids close N-type voltage-operated calcium channels and open calcium-dependent inwardly rectifying potassium channels. This results in hyperpolarization and reduced neuronal excitability. Morphine acts at A delta and C pain fibres in the dorsal horn of the spinal cord. By decreasing neurotransmitter action there is less pain transmittance into the spinal cord. This leads to less pain perception.
|
Creator: Ray Kruger Created On: August 28, 2023 at 13:31 Last Updated: August 28, 2023 at 13:31 |
PW176399View Pathway |
Piritramide Predicted Metabolism PathwayHomo sapiens
Metabolites of Piritramide are predicted with biotransformer.
|
Creator: Omolola Created On: December 07, 2023 at 16:49 Last Updated: December 07, 2023 at 16:49 |
PW122252View Pathway |
drug action
Piroxicam Action Action Pathway XuanHomo sapiens
Piroxicam is a nonsteroidal oxicam derivative with anti-inflammatory, antipyretic and analgesic properties. As a non-selective, nonsteroidal anti-inflammatory drug (NSAID), piroxicam binds and chelates both isoforms of cyclooxygenases (COX1 and COX2), thereby stalling phospholipase A2 activity and conversion of arachidonic acid into prostaglandin precursors at the rate limiting cyclooxygenase enzyme step. This results in inhibition of prostaglandin biosynthesis. As a second, independent effect, piroxicam inhibits the activation of neutrophils thereby contributing to its overall anti-inflammatory effects. Piroxicam will be transported via Solute carrier family 22 member 6, Solute carrier family 22 member 8, Solute carrier family 22 member 11 and Solute carrier organic anion transporter family member 2B1 into cell. After get into cell, piroxicam will inhibit the Prostaglandin G/H synthase 2 and Prostaglandin G/H synthase 1's function; so that Prostaglandin G2 couldn't be transferred into Prostaglandin H2.
|
Creator: xuan cao Created On: October 14, 2018 at 17:49 Last Updated: October 14, 2018 at 17:49 |
PW122274View Pathway |
drug action
Piroxicam Action Action Pathway Xuan (Demo Purpose)Homo sapiens
|
Creator: xuan cao Created On: October 29, 2018 at 14:59 Last Updated: October 29, 2018 at 14:59 |